Scarica l'app Stockscreener
47.86
0.33%
-0.16
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Gsk Plc Adr Borsa (GSK) Ultime notizie
GSK PLC Sponsored ADR (NYSE:GSK) Receives Average Rating of “Hold” from Analysts - Defense World
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire Inc.
GSK plc Stock Today, 28 November 2025: Buybacks, ‘Hold’ Ratings and Pipeline Momentum Keep Shares Near Highs - ts2.tech
Rep. Lisa C. McClain Sells Off Shares of GSK PLC Sponsored ADR (NYSE:GSK) - Defense World
Looking To Buy GSK Plc ADR (GSK)? Read This First - fostersleader.com
GSK (NYSE:GSK) Stock Unloaded Rep. Lisa C. McClain - Defense World
Zacks Research Issues Pessimistic Estimate for GSK Earnings - Defense World
Zacks Research Weighs in on GSK’s FY2025 Earnings (NYSE:GSK) - Defense World
JPMorgan Lowers GSK Price Target, Maintains Underweight Rating - Finviz
Alector Stock Plummets 63% in a Month: Here's What You Need to Know - Finviz
Eli Lilly Upgraded, Chewy Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
GSK PLC Share Price: What to Know Before the London Market Opens on 17 November 2025 - ts2.tech
GILD's Investigational Regimen for HIV Treatment Meets Primary Goal - Finviz
The Best Healthcare Stock to Hold in Uncertain Times - Finviz
Why GSK (GSK) is a Top Growth Stock for the Long-Term - Yahoo Finance
Looking Into GSK PLC's Recent Short Interest - Sahm
3 Dividend Stocks for November 2025 - Morningstar
10 Best Value Stocks to Buy for the Long Term - Morningstar
GSK PLC Sponsored ADR (NYSE:GSK) Given Average Rating of "Hold" by Analysts - MarketBeat
Arkadios Wealth Advisors Acquires 6,734 Shares of GSK PLC Sponsored ADR $GSK - MarketBeat
GSK PLC Sponsored ADR Plans Quarterly Dividend of $0.42 (NYSE:GSK) - MarketBeat
GSK's Vaccine and HIV Portfolios Support Ongoing Innovation in Oncology and Immunology - Morningstar
GSK's Q3 Earnings & Sales Beat Estimates, Stock Up on Raised '25 View - TradingView
GSK Upgrades 2025 Financial Outlook, CEO Says Positioned Well For 2026 - Sahm
Here's Why GSK (GSK) is a Strong Growth Stock - Yahoo Finance
ETFs Investing in GSK plc Sponsored ADR Stocks - TradingView
Whittier Trust Co. Sells 5,805 Shares of GSK PLC Sponsored ADR $GSK - MarketBeat
GSK plc Sponsored ADR (GSK) Stock Forecast & Price Targets: Today, Tomorrow, Next Week - Traders Union
GSK plc Sponsored ADR (GSK) Stock Price Prediction for 2025, 2026, 2030-2040 - Traders Union
FDA Approves GSK's Withdrawn Blood Cancer Drug Blenrep - Sahm
J.P. Morgan Sticks to Its Sell Rating for GlaxoSmithKline (GSK) - The Globe and Mail
GSK PLC Sponsored ADR $GSK Shares Acquired by Ethic Inc. - MarketBeat
Clinical Failure Halts Alector's Dementia Program, Company Reduces Workforce - Sahm
GSK (GSK) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance
Stanley Laman Group Ltd. Decreases Stock Holdings in GSK PLC Sponsored ADR $GSK - MarketBeat
UK Health Agency Recommends GSK-Backed ViiV Healthcare's Apretude As Injectable HIV Treatment - Sahm
The Best Healthcare Stocks to Buy - Morningstar
Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential - Sahm
Rep. Val T. Hoyle Sells GSK PLC Sponsored ADR (NYSE:GSK) Stock - MarketBeat
GSK PLC Sponsored ADR (NYSE:GSK) Receives Average Recommendation of "Reduce" from Brokerages - MarketBeat
Gilead Resolves Patent Litigations for HIV Treatment Biktarvy - The Globe and Mail
AstraZeneca Upgraded, Home Depot Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Will Glaxo (GSK) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Why GSK (GSK) is a Top Value Stock for the Long-Term - sharewise.com
0.30%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):